TRIP key facts
as of Oct 2026- Producer of beverages and oils intended for CBD hemp and extracts for medicinal and recreational purposes.
- TRIP is valued at approximately $144.3M as of Oct 2026 (last reported valuation).
- It has raised $80.8M; the latest was Secondary Transaction - Private ($5.7M) in Jan 2026.
- Notable investors include Coefficient Capital, Maria Raga, 029 Group, Alessandra Ambrosio, Ashley Graham — 13 tracked in total.
- Status: Privately Held (backing).
TRIP's last reported valuation, Apr 2025. Nothing priced has surfaced since.
- ·The complete investor list: 13 names
- ·Watch TRIP: the Monday email on marks, rounds and moves
TRIP funding rounds
No funding rounds for TRIP are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs TRIP
13+Membership and data by Private Market View
TRIP valuation
TRIP's last reported valuation was $144 million in Apr 2025. No priced round, secondary trade or fund mark has surfaced since.
TRIP investors
13 investors are on record for TRIP, including Coefficient Capital, Maria Raga, 029 Group and Alessandra Ambrosio.
About TRIP
Producer of beverages and oils intended for CBD hemp and extracts for medicinal and recreational purposes. The company specializes in producing various CBD-infused beverages used for relaxing, getting rid of anxiety, and treating anti-inflammatory diseases, allowing customers to get CBD oils for smaller everyday stresses.
- Sector
- Consumer Products and Services (B2C)
- HQ
- London, United Kingdom
- Founded
- 2019
- Employees
- 186
- Website
- drink-trip.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.